QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

PRCT

QT56PROCEPT BioRobotics Corporation
NASDAQ·Healthcare·Medical - Devices·USA
Latest market price
21.72
+0.81+3.87%
OverviewShort InterestFilings
PRCTQT56PROCEPT BioRobotics Corporation·NASDAQ
OverviewShort InterestFilings
21.72+3.87%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E-EPS (ttm)-1.82
Insider Own-
Shs Outstand56.92M
Perf Week-21.56%
Market Cap1.19BForward P/E-EPS next Y-0.92Insider Trans0.71%Shs Float-Perf Month-16.17%
Enterprise Value996.20MPEG1.28EPS next Q-0.45Inst Own-Short Float-Perf Quarter-15.42%
Income-103187998.00P/S3.70EPS this Y15.99%Inst Trans-Short Ratio-Perf Half Y-39.09%
Sales322.03MP/B3.40EPS next Y39.97%ROA-21.04%Short Interest-Perf YTD-30.96%
Book/sh6.11P/C-EPS next 5Y-ROE-27.70%52W High62.16 -65.06%Perf Year-63.20%
Cash/sh4.32P/FCF-EPS past 3/5Y-ROIC-25.75%52W Low19.35 12.25%Perf 3Y-
Dividend Est.-EV/EBITDA-10.82Sales past 3/5Y60.14% 107.54%Gross Margin62.98%Volatility4.79% 4.34%Perf 5Y-
Dividend TTM-EV/Sales3.09EPS Y/Y TTM-4.00%Oper. Margin-33.86%ATR (14)1.79Perf 10Y-
Dividend Ex-Date-Quick Ratio5.51Sales Y/Y TTM43.30%Profit Margin-31.82%RSI (14)35.25Recom2.60
Dividend Gr. 3/5Y-Current Ratio6.73EPS Q/Q-24.44%SMA20-17.84%Beta0.90Target Price32.00
Payout0.00%Debt/Eq0.15Sales Q/Q20.29%SMA50-15.11%Rel Volume1.17Prev Close20.91
Employees756LT Debt/Eq0.14EarningsAug 05SMA200-27.62%Avg Volume1.52MPrice21.72
IPO DateSep 15, 2021Option/ShortYes / YesEPS/Sales Surpr.-1.82% 2.47%Net Debt/EBITDA2.11Volume1,780,817Change3.87%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-11-26DowngradeLeerink PartnersOutperform → Market Perform$55 → $29
Apr-30-26ReiteratedPiper SandlerOverweight$50 → $35
Feb-27-26ReiteratedTruist Financial$47 → $30
Feb-26-26ReiteratedWells FargoOverweight$51 → $34
Feb-26-26DowngradeOppenheimerOutperform → Perform
Feb-26-26DowngradeB of A SecuritiesNeutral → Underperform
Dec-18-25ReiteratedTruist Financial$50 → $47
Dec-12-25ReiteratedUBS$62
Dec-08-25DowngradeB of A SecuritiesBuy → Neutral
Dec-02-25ReiteratedMorgan StanleyOverweight$105 → $51
Latest News
Jun-11-26
Jun-11-2611:42AM
This MarketAxess Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For ThursdayBenzinga
10:33AM
Leerink Partners Downgrades PROCEPT BioRobotics to Market Perform, Lowers Price Target to $29Benzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
Total Revenue321308224
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A11911287
Gross Profit202196137
Selling, General and Administrative Excl. Other238229171
Research and Development737162
Other Operating Expense101
Operating Income-109-104-97
Interest Expense444
Unusual Expense
———
Non-Operating Income (Expense)-11-12-9
Net Income Before Taxes-103-95-91
Income Taxes
000
Consolidated Net Income-103-96-91
Net Income From Continuing Operations-103-96-91
Net Income-103-96-91
EPS (Recurring)-1.82-1.72-1.75
EPS (Basic, Before Extraordinaries)-1.82-1.72-1.75
EPS (Diluted)-1.82-1.72-1.75
EBITDA-92-85-82
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio3.865.72—
Gross Margin62.9363.6461.16
Operating Margin-33.96-33.77-43.30
Net Margin-32.09-31.17-40.63
Shares Outstanding575652
Market Capitalization1,2381,762—
Operating Lease Expense
———
Insider Trading Volume
$22.62$20.67$18.72$16.77$14.82● Close Price0.00M2.67M5.33M8.00M10.66MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Nouri AlalehEVP, CLO, CORP. SEC.Jun 08 '26Sale28.482858,117105,069Jun 10 12:00 AM
Waters KevinEVP, CFOJun 08 '26Sale28.4835710,167151,201Jun 10 12:00 AM
Templin Barry LEVP, Chief Technology OfficerJun 08 '26Sale28.4835810,19568,953Jun 10 12:00 AM
Nouri AlalehEVP, CLO, CORP. SEC.Mar 19 '26Sale25.965,363139,230105,354Mar 19 12:00 AM
Nouri AlalehEVP, CLO, CORP. SEC.Mar 17 '26Sale28.153048,559110,717Mar 19 12:00 AM
Waters KevinEVP, CFOMar 17 '26Sale28.1570619,876151,558Mar 19 12:00 AM
Nouri AlalehEVP, CLO, CORP. SEC.Mar 10 '26Sale25.653,24383,197111,021Mar 12 12:00 AM
Desai Antal RohitDirectorMar 09 '26Buy24.5598,6992,422,890426,262Mar 09 12:00 AM
Nouri AlalehEVP, CLO, CORP. SEC.Mar 06 '26Sale23.706,892163,353114,264Mar 09 12:00 AM
Desai Antal RohitDirectorMar 06 '26Buy23.59160,3173,781,503327,563Mar 09 12:00 AM
Waters KevinEVP, CFOMar 06 '26Sale23.706,721159,300152,264Mar 09 12:00 AM
Desai Antal RohitDirectorMar 05 '26Buy25.58167,2464,278,549167,246Mar 09 12:00 AM
Desai Antal RohitDirectorAug 14 '25Option Exercise1.3353,49871,15235,152Aug 15 12:00 AM
Nouri AlalehEVP, CLO, CORP. SEC.Aug 14 '25Option Exercise4.5222,00099,44072,473Aug 14 12:00 AM
MOLL FREDERIC HDirectorAug 13 '25Buy39.2620,000785,138863,159Aug 14 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR